Endotoxin in pooled pericardial blood contributes to the systemic inflammatory response during cardiac surgery

Perfusion

Volumn 15, Issue 5, 2000, Pages 427-431

  Spanier, Talia ^a   Tector, Kelly ^a   Schwartz, Graham ^a   Chen, Jonathan ^a   Oz, Mehmet ^a   Beck, James ^a   Mongero, Linda ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; AORTA CLAMPING; ARTICLE; BLOOD ANALYSIS; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTAMINATION; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; INFECTION RISK; MALE; PERICARDIUM; PRIORITY JOURNAL; PROTEIN DETERMINATION; RISK FACTOR; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; CARDIOPULMONARY BYPASS; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EQUIPMENT AND SUPPLIES; FEMALE; HUMANS; INFLAMMATION; LIMULUS TEST; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PERICARDIUM; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033835438     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765910001500504     Document Type: Article

References (12)

1. Why cardiopulmonary bypass makes patients sick: Strategies to control the blood synthetic surface interaction
2. Inflammatory response to cardiopulmonary bypass. Mechanisms involved and possible therapeutic strategies
3. Blood-surface interactions during cardiopulmonary bypass
4. What initiates the systemic inflammatory response in cardiac surgery?
5. Endotoxemia and enhanced generation of oxygen radical by neutrophils undergoing cardiopulmonary bypass
6. Presence of circulating endotoxins during cardiac operations
7. Relationship of preoperative antiendotoxin core antibodies and adverse outcome following cardiac surgery
8. Relationship between preoperative endotoxin immune status, gut barrier perfusion, and outcome from cardiac valve replacement surgery
9. Can selective digestive decontamination avoid the endotoxemia and cytokine activation promoted by cardiopulmonary bypass?
10. Intestinal permeability, gastric pH, and systemic endotoxemia in patient undergoing cardiopulmonary bypass
11. Down-regulation of surface monocyte lipopolysaccharide receptor CD14 in patients on cardiopulmonary bypass undergoing aorta-coronary bypass operations
12. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass